44th Annual Carrell Krusen Virtual Neuromuscular Symposium (RP2202A)

February 24, 2022 to February 25, 2022

This virtual, live-streamed symposium is a clinical education experience for members of multidisciplinary teams who care for patients with rare, complex neuromuscular diseases including hereditary muscular dystrophies, motor neuron diseases, neuroimmunologic neuropathies and rare genetic disorders of muscle and nerve. Case presentations will include physical diagnosis and discussion of management and new therapies by participating experts. All discussions involve active participation by attendees. The educational format for this activity includes didactic lectures with in depth Q&A, panel discussions, and PowerPoint Presentations. The content of the program is identified and developed through a Call for Abstracts process. The 2022 keynote speaker will present data from the latest clinical trials for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

Click on the Register tab to save your spot! Registration will close at 7 am CST on Thursday, Feb 24th.

CLICK HERE TO VIEW THE AGENDA

Registration TypeBefore 2/17/22

After 2/17/ 22

Physicians$100$110
Fellows/Residents/Medical Students$0$10
Advanced Practice Providers (PA/NP)/Nurses$0$10
Other Healthcare Providers (OT/PT, SPL, Research Coordinators)$0$10
Exhibit/Industry Representative$150$160

We are proud to announce that the 2022 Keynote Speaker is 

Eva Feldman, M.D., Ph.D.
Russell N. DeJong Professor of Neurology
Director, ALS Center of Excellence
University of Michigan

Target Audience

This program is specifically designed for Primary Care providers, Neurologists, NPs, PAs, and RNs that desire to gain advanced knowledge in diagnosis and management of patients with neuromuscular disease.

Learning Objectives

  • Discuss the elements in formulating a diagnosis and management plan for rare genetic diseases such as Amyotrophic Lateral Sclerosis (ALS).
  • Discuss recent advances in the genetic diagnosis of neuromuscular disorders, in research and clinical practice and the latest developments in treatment such as gene replacement therapy.
  • Identify and apply current pharmacological and non-pharmacological treatments in motor neuron diseases including gene replacement therapy
  • Identify considerations for effective care coordination of patients with neuromuscular disease
  • Recognize the clinical applications of testing in neuromuscular disorders (to include histopathology).
Course summary
Available credit: 
  • 8.00 AMA
  • 8.00 Attendance
Course opens: 
09/01/2021
Course expires: 
02/24/2023
Event starts: 
02/24/2022 - 9:25am CST
Event ends: 
02/25/2022 - 4:00pm CST
Cost:
$100.00
Rating: 
0
Virtual Course
Dallas, TX
United States
Committee member(s)

Kaitlin Batley, MD

has no relevant financial relationships to disclose at this time.

Salman Bhai

has a financial relationship (Independent contractor) with Alnylam;.
has a financial relationship (Independent contractor) with KabaFusion;.

Elena Caron, MD

has no relevant financial relationships to disclose at this time.

Diana Castro, Assistant Professor of Pediatrics, Neurology and Neurotherapeutics

has a financial relationship (Professional Services) with Biogen, Sarepta, ReveraGen, Fibrogen, PTC;.

Susan Iannaccone, MD

has a financial relationship (Grant Or Contract) with Biogen;.
has a financial relationship (Grant Or Contract) with Regeneron;.
has a financial relationship (Grant Or Contract) with Parent Project for Muscular Dystrophy;.
has a financial relationship (Grant Or Contract) with PTC Therapeutics;.
has a financial relationship (Grant Or Contract) with Cure SMA;.
has a financial relationship (Independent contractor) with Biogen;.
has a financial relationship (Grant Or Contract) with Sarepta;.
has a financial relationship (Grant Or Contract) with MDA;.
has a financial relationship (Grant Or Contract) with Department of Defense;.
has a financial relationship (Grant Or Contract) with Avexis;.
has a financial relationship (Grant Or Contract) with Scholar Rock;.
has a financial relationship (Grant Or Contract) with Pfizer;.

Anne Marie Jones, MS, BSN, RN

has no relevant financial relationships to disclose at this time.

Shaida Khan, D.O.

has a financial relationship (Professional Services) with Alexion;.
has a financial relationship (Professional Services) with Argenx;.
has a financial relationship (Professional Services) with Ra Pharma;.

Ariel Marks

has no relevant financial relationships to disclose at this time.

Lauren Phillips, MD

has no relevant financial relationships to disclose at this time.

Jaya Trivedi, MD, FAAN, FANA

has a financial relationship (Professional Services) with ArgenX;.

Steven Vernino, MD, PhD, FAAN, FANA, FAAS

has a financial relationship (Professional Services) with Alterity;.
has a financial relationship (Grant Or Contract) with Dysautonomia International;.
has a financial relationship (Grant Or Contract) with Quest Diagnostics;.
has a financial relationship (Grant Or Contract) with Theravance;.
has a financial relationship (Professional Services) with Sage Therapeutics;.
has a financial relationship (Grant Or Contract) with BioHaven;.
has a financial relationship (Grant Or Contract) with Grifols;.
has a financial relationship (Fiduciary officer) with American Autonomic Society;.
has a financial relationship (Professional Services) with Genentech;.
Course Director(s)

Diana Castro, Assistant Professor of Pediatrics, Neurology and Neurotherapeutics

has a financial relationship (Professional Services) with Biogen, Sarepta, ReveraGen, Fibrogen, PTC;.

Susan Iannaccone, MD

has a financial relationship (Grant Or Contract) with Parent Project for Muscular Dystrophy;.
has a financial relationship (Grant Or Contract) with Biogen;.
has a financial relationship (Grant Or Contract) with Regeneron;.
has a financial relationship (Grant Or Contract) with Cure SMA;.
has a financial relationship (Independent contractor) with Biogen;.
has a financial relationship (Grant Or Contract) with PTC Therapeutics;.
has a financial relationship (Grant Or Contract) with Department of Defense;.
has a financial relationship (Grant Or Contract) with Sarepta;.
has a financial relationship (Grant Or Contract) with MDA;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with Avexis;.
has a financial relationship (Grant Or Contract) with Scholar Rock;.

Jaya Trivedi, MD, FAAN, FANA

has a financial relationship (Professional Services) with ArgenX;.
Moderator(s)

Claudia Chiriboga, MD, MPH, FAAN

has a financial relationship (Grant Or Contract) with Roche;.
has a financial relationship (Professional Services) with Roche;.
has a financial relationship (Professional Services) with Genentec;.
has a financial relationship (Grant Or Contract) with Biogen;.
has a financial relationship (Professional Services) with PTC;.
has a financial relationship (Grant Or Contract) with Avexis/Novartis;.
has a financial relationship (Professional Services) with Avexis/Novartis;.

Christopher Doughty, MD

has a financial relationship (Independent contractor) with Dysimmune Diseases Foundation;.
has a financial relationship (Independent contractor) with Argenx;.
has a financial relationship (Independent contractor) with Oakstone Publishing;.

Divyanshu Dubey

has a financial relationship (Professional Services) with Astellas;.
has a financial relationship (Professional Services) with UCB;.
has a financial relationship (Professional Services) with Immunovant ;.

Lisa Hobson-Webb, MD, FAAN

has a financial relationship (Employment) with G1 Therapeutics Inc;.
has a financial relationship (Independent contractor) with Wiley Publishing;.

Emer McGrath, MB, BCh, MRCP, PhD

has no relevant financial relationships to disclose at this time.

vamshi rao

has a financial relationship (Professional Services) with Honoraria ;.

Sarada Sakamuri, MD

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

Brittney Rhem, MD

has no relevant financial relationships to disclose at this time.

Jenny Riecke

has no relevant financial relationships to disclose at this time.

Divya Shah

has no relevant financial relationships to disclose at this time.
Planner(s)

Diana Castro, Assistant Professor of Pediatrics, Neurology and Neurotherapeutics

has a financial relationship (Professional Services) with Biogen, Sarepta, ReveraGen, Fibrogen, PTC;.

Susan Iannaccone, MD

has a financial relationship (Grant Or Contract) with Biogen;.
has a financial relationship (Grant Or Contract) with Regeneron;.
has a financial relationship (Grant Or Contract) with Parent Project for Muscular Dystrophy;.
has a financial relationship (Grant Or Contract) with PTC Therapeutics;.
has a financial relationship (Grant Or Contract) with Cure SMA;.
has a financial relationship (Independent contractor) with Biogen;.
has a financial relationship (Grant Or Contract) with Sarepta;.
has a financial relationship (Grant Or Contract) with MDA;.
has a financial relationship (Grant Or Contract) with Department of Defense;.
has a financial relationship (Grant Or Contract) with Avexis;.
has a financial relationship (Grant Or Contract) with Scholar Rock;.
has a financial relationship (Grant Or Contract) with Pfizer;.

Anne Marie Jones, MS, BSN, RN

has no relevant financial relationships to disclose at this time.

Lauren Phillips, MD

has no relevant financial relationships to disclose at this time.

Jaya Trivedi, MD, FAAN, FANA

has a financial relationship (Professional Services) with ArgenX;.

Steven Vernino, MD, PhD, FAAN, FANA, FAAS

has a financial relationship (Professional Services) with Sage Therapeutics;.
has a financial relationship (Grant Or Contract) with Theravance;.
has a financial relationship (Grant Or Contract) with Grifols;.
has a financial relationship (Grant Or Contract) with BioHaven;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Fiduciary officer) with American Autonomic Society;.
has a financial relationship (Grant Or Contract) with Quest Diagnostics;.
has a financial relationship (Professional Services) with Alterity;.
has a financial relationship (Grant Or Contract) with Dysautonomia International;.
Speaker(s)

Farida Abid, Assistant professor

has no relevant financial relationships to disclose at this time.

Khalid Alrasheed, MBBS, FRCPC

has no relevant financial relationships to disclose at this time.

Anthony Amato, MD

has no relevant financial relationships to disclose at this time.

Abhiram Bhashyam, MD, PhD

has no relevant financial relationships to disclose at this time.

Ratna Bhavaraju-Sanka, MD

has a financial relationship (Professional Services) with Argenyx ;.

Sarah Bivans, Medical Student, 2nd year

has no relevant financial relationships to disclose at this time.

Chunyu Cai, Assistant Professor

has no relevant financial relationships to disclose at this time.

Karla Castro Ochoa

has no relevant financial relationships to disclose at this time.

Kathy Chuang, MD

has no relevant financial relationships to disclose at this time.

Eleonora Silvana D'Ambrosio

has no relevant financial relationships to disclose at this time.

William David

has no relevant financial relationships to disclose at this time.

Jonathan Donnelly, MBBS, MRCP(UK)

has no relevant financial relationships to disclose at this time.

Eva Feldman, Eva L. Feldman, MD, PhD Russell N.DeJong Professor of Neurology

has no relevant financial relationships to disclose at this time.

Emily Filmore, Patient

has no relevant financial relationships to disclose at this time.

James Gibson

has a financial relationship (Grant Or Contract) with Mandos, LLC;.
has a financial relationship (Grant Or Contract) with Mallinckrodt Pharmaceutical;.

Andrea Gilbert, Neuropathologist

has no relevant financial relationships to disclose at this time.

Osniel Gonzalez Ramos

has no relevant financial relationships to disclose at this time.

Paloma Gonzalez-Perez

has no relevant financial relationships to disclose at this time.

Namita Goyal

has no relevant financial relationships to disclose at this time.

Benjamin Greenberg

has a financial relationship (Grant Or Contract) with Clene Nanomedicine;.
has a financial relationship (Independent contractor) with Ruben Anders;.
has a financial relationship (Independent contractor) with Alexion;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with Horizon Therapeutics;.
has a financial relationship (Independent contractor) with Immunovant;.
has a financial relationship (Independent contractor) with EMD Serono;.
has a financial relationship (Independent contractor) with Abcam;.
has a financial relationship (Independent contractor) with IQVIA;.
has a financial relationship (Independent contractor) with Novartis;.
has a financial relationship (Independent contractor) with Greenwhich Bio;.
has a financial relationship (Independent contractor) with Sanofi/Genzyme;.

Komal Hafeez

has no relevant financial relationships to disclose at this time.

Avneet Hans, Anticipated MD in 2022

has no relevant financial relationships to disclose at this time.

Natalie Katz, MD, PhD

has no relevant financial relationships to disclose at this time.

Vindhya Koneru, MD

has no relevant financial relationships to disclose at this time.

Yoona Lee, MS4

has no relevant financial relationships to disclose at this time.

Joy Lin, MD

has no relevant financial relationships to disclose at this time.

MANUEL LUBINUS

has no relevant financial relationships to disclose at this time.

Samuel Mackenzie, MD, PhD

has a financial relationship (Independent contractor) with Freespira;.
has a financial relationship (Independent contractor) with Everyday Health, Inc.;.
has a financial relationship (Intellectual Property Other) with Phlow Corp.;.

Pradeep Mammen, Associate Professor of Internal Medicine; Alfred W. Harris, M.D. Professorship in Cardiology

has a financial relationship (Grant Or Contract) with Catabasis Inc.;.
has a financial relationship (Grant Or Contract) with PhaseBio Inc.;.
has a financial relationship (Grant Or Contract) with CareDx Inc.;.
has a financial relationship (Grant Or Contract) with National Institute of Health;.
has a financial relationship (Financial Support) with California Institute for Regenerative Medicine;.
has a financial relationship (Financial Support) with HeartWare Inc.;.
has a financial relationship (Financial Support) with American Heart Association;.

Tahseen Mozaffar, MD, FAAN, FANA

has a financial relationship (Independent contractor) with Spark Therapeutic;.
has a financial relationship (Independent contractor) with Amicus;.
has a financial relationship (Independent contractor) with Abbvie;.
has a financial relationship (Independent contractor) with Sanofi Genzyme;.
has a financial relationship (Independent contractor) with CSL;.
has a financial relationship (Independent contractor) with Alexion;.

Srikanth Muppidi

has a financial relationship (Professional Services) with Advisory Board meeting for ARGENX;.
has a financial relationship (Professional Services) with Advisory Board Meeting for Alexion;.
has a financial relationship (Professional Services) with Advisory Board meeting for UCB pharma;.

Naraharisetty Rau, MD

has no relevant financial relationships to disclose at this time.

Sahar Sheikhbahaei

has no relevant financial relationships to disclose at this time.

Akhil Shivaprasad, MD

has no relevant financial relationships to disclose at this time.

Sheetal Shroff, MD

has no relevant financial relationships to disclose at this time.

Ashley Stanley-Copeland, MD

has no relevant financial relationships to disclose at this time.

David Stevens, MD

has no relevant financial relationships to disclose at this time.

Anishee Undavia

has no relevant financial relationships to disclose at this time.

Vettaikorumakankav Vedanarayanan, MD, FRCPC

has no relevant financial relationships to disclose at this time.

Thurman Wheeler

has no relevant financial relationships to disclose at this time.

Jerry Williams

has no relevant financial relationships to disclose at this time.

Lynn Wilson

has no relevant financial relationships to disclose at this time.

ACCREDITATION AND DESIGNATION STATEMENTS

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

UT Southwestern Medical Center is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 4.00 contact hours for Day #1 and 3.82 contact hours for Day #2. Registered Nurses must provide official name, credentials, and email address during the symposium registration process, actively participate in the activity, and complete the post-symposium evaluation for each day of attendance. Credit will be awarded for each full day of attendance. Learning outcome: 70% of registered nurses will self-report increased knowledge of rare, complex neuromuscular diseases and current treatment options.

 

 

Available Credit

  • 8.00 AMA
  • 8.00 Attendance

Price

Cost:
$100.00
Please login or create an account to take this course.